Mohammed Afroz Bakht (Md Afroz Bakht, Md Afroz Bakht)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 12

Top Topics

Tyrosine Kinase

Molecular Docking

Advanced Non Small Cell Lung Cancer

Top Venues

Molecules (Basel, Switzerland)

Plants (Basel, Switzerland)

Expert opinion on therapeutic patents

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammed Afroz Bakht, Thangaiyan Pooventhiran, Renjith Thomas, Mehnaz Kamal, Israf Ud Din, Najeeb Ur Rehman, Imtiaz Ali, Noushin Ajmal, Mohamed Jawed Ahsan
Synthesis and Biological Evaluation of Octahydroquinazolinones as Phospholipase A2, and Protease Inhibitors: Experimental and Theoretical Exploration. Molecules (Basel, Switzerland) 28 (4) (2023)
Mohammed Afroz Bakht, Thangaiyan Pooventhiran, Renjith Thomas, Mehnaz Kamal, Israf Ud Din, Najeeb Ur Rehman, Imtiaz Ali, Noushin Ajmal, Mohamed Jawed Ahsan
Synthesis and Biological Evaluation of Octahydroquinazolinones as Phospholipase A2, and Protease Inhibitors: Experimental and Theoretical Exploration. Molecules (Basel, Switzerland) 28 (4) (2023)
Mohammed Afroz Bakht, Thangaiyan Pooventhiran, Renjith Thomas, Mehnaz Kamal, Israf Ud Din, Najeeb Ur Rehman, Imtiaz Ali, Noushin Ajmal, Mohamed Jawed Ahsan
Synthesis and Biological Evaluation of Octahydroquinazolinones as Phospholipase A2, and Protease Inhibitors: Experimental and Theoretical Exploration. Molecules (Basel, Switzerland) 28 (4) (2023)
Mohammed Afroz Bakht, Thangaiyan Pooventhiran, Renjith Thomas, Mehnaz Kamal, Israf Ud Din, Najeeb Ur Rehman, Imtiaz Ali, Noushin Ajmal, Mohamed Jawed Ahsan
Synthesis and Biological Evaluation of Octahydroquinazolinones as Phospholipase A2, and Protease Inhibitors: Experimental and Theoretical Exploration. Molecules (Basel, Switzerland) 28 (4) (2023)
Mohammed Afroz Bakht, Thangaiyan Pooventhiran, Renjith Thomas, Mehnaz Kamal, Israf Ud Din, Najeeb Ur Rehman, Imtiaz Ali, Noushin Ajmal, Mohamed Jawed Ahsan
Synthesis and Biological Evaluation of Octahydroquinazolinones as Phospholipase A2, and Protease Inhibitors: Experimental and Theoretical Exploration. Molecules (Basel, Switzerland) 28 (4) (2023)
Obaid Afzal, Amena Ali, Abuzer Ali, Abdulmalik Saleh Alfawaz Altamimi, Manal A Alossaimi, Mohammed Afroz Bakht, Salahuddin Salahuddin, Mubarak A Alamri, Md Faiyaz Ahsan, Mohamed Jawed Ahsan
Synthesis and Anticancer Evaluation of 4-Chloro-2-((5-aryl-1,3,4-oxadiazol-2-yl)amino)phenol Analogues: An Insight into Experimental and Theoretical Studies. Molecules (Basel, Switzerland) 28 (16) (2023)
Mohamed Jawed Ahsan, Kavita Choudhary, Amena Ali, Abuzer Ali, Faizul Azam, Atiah H Almalki, Eman Y Santali, Mohammed Afroz Bakht, Abu Tahir, Salahuddin Salahuddin
Synthesis, DFT Analyses, Antiproliferative Activity, and Molecular Docking Studies of Curcumin Analogues. Plants (Basel, Switzerland) 11 (21) (2022)
Obaid Afzal, Mohammad Yusuf, Mohamed Jawed Ahsan, Abdulmalik S A Altamimi, Mohammed Afroz Bakht, Amena Ali, null Salahuddin
Chemical Modification of Curcumin into Its Semi-Synthetic Analogs Bearing Pyrimidinone Moiety as Anticancer Agents. Plants (Basel, Switzerland) 11 (20) (2022)
Amena Ali, Abuzer Ali, Abu Tahir, Mohammed Afroz Bakht, Mohamed Jawed Ahsan
Ultrasound promoted green synthesis, anticancer evaluation, and molecular docking studies of hydrazines: a pilot trial. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Amena Ali, Abuzer Ali, Abu Tahir, Mohammed Afroz Bakht, null Salahuddin, Mohamed Jawed Ahsan
Molecular Engineering of Curcumin, an Active Constituent of Curcuma longa L. (Turmeric) of the Family Zingiberaceae with Improved Antiproliferative Activity. Plants (Basel, Switzerland) 10 (8) (2021)
Mohd Imran, Ahmed Subeh Alshrari, Hamdy Kh Thabet, Abida Khan, Mohammed Afroz Bakht
Synthetic molecules as DprE1 inhibitors: A patent review. Expert opinion on therapeutic patents 31 (8) (2021)
Mohd Imran, Syed Mohammed Basheeruddin Asdaq, Shah Alam Khan, Dhanalekshmi Unnikrishnan Meenakshi, Abdulhakeem S Alamri, Walaa F Alsanie, Majid Alhomrani, Yahya Mohzari, Ahmed Alrashed, Mohammed AlMotairi, Eman H Alkhaldi, Abeer K Alorabi, Ahmed Subeh Alshrari, Mohammad Tauseef, Abida Khan, Saleh I Alaqel, Ozair Alam, Mohammed Afroz Bakht
Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)